MONTREAL (AP) — MONTREAL (AP) — Milestone Pharmaceuticals Inc. (MIST) on Friday reported a loss of $17.4 million in its fourth quarter.

On a per-share basis, the Montreal-based company said it had a loss of 16 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

The biotechnology company posted revenue of $1.5 million in the period.

For the year, the company reported a loss of $63.1 million, or 75 cents per share. Revenue was reported as $1.5 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MIST at https://www.zacks.com/ap/MIST

Source